Published in Medical Patent Law Weekly, August 10th, 2005
Under the terms of the arrangement, PPTI would acquire Surgica's assets with a combination of PPTI common stock and cash. Assets comprise intellectual property including one issued patent, product lines and a U.S. Food and Drug Administration (FDA)-approved manufacturing facility. The company currently has three FDA- approved polyvinyl alcohol (PVA) product lines - PVA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly